Clinical Trial Update: Reconstructive Therapy of Peri-implantitis with PDGF-BB (Gem-21) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating reconstructive therapy for peri-implantitis using Gem-21 (platelet-derived growth factor-BB) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peri-implantitis

Drugs mentioned

• Gem-21 (platelet-derived growth factor-BB (PDGF-BB))

Snippet

Sponsor: Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain | Conditions: Peri-Implantitis | Phase 4 | Status: COMPLETED